Article ID Journal Published Year Pages File Type
6190437 Cancer Treatment Reviews 2016 8 Pages PDF
Abstract
MAP-kinase inhibitors and immunologic checkpoint blockade antibodies have clinical activity and may achieve improved OS in patients with metastatic melanoma and BM. These results support the inclusion of patients with BM in investigations of new agents and new treatment regimens for metastatic melanoma.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review
Authors
, , , , , ,